Monitoring of Serum Her-2/<b> <i>neu</i> </b> Predicts Response and Progression-Free Survival to Trastuzumab-Based Treatment in Patients with Metastatic Breast Cancer
2004 · Clinical Cancer Research · 144 citations
https://doi.org/10.1158/1078-0432.ccr-0385-3